Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCI with propofol and remifentanil for burn wound care sedation
2013-000476-14Phase 2Completed
- Sponsor
- Region Östergötland
- Start
- Mar 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of propofol, remifentanil and fentanyl in burn injury (2 arms), sponsored by Region Östergötland. Primary endpoint: Time to recovery after analgo-sedation. Started Mar 2013; status: completed.
02
Drugs
propofolremifentanilfentanyl
03
Conditions
burn injury
Beyond the preview
Go deeper on 2013-000476-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000476-14.